RHYTHM PHARMACEUTICALS, INC. (RYTM) insider trading

By person

15 insiders · 52 transactions

31.1×

David P. Meeker holds 31.1 times base salary in stock. $25.17M of shares against $807.69K in salary for 2025.

Salary from the company's own proxy. The shares are what David P. Meeker last reported holding, valued at $105.19, the price Common Stock was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Jennifer Kayden Lee

EVP, Head of North America

—

$8.90M (1) scheduled

−$8.90M

0.0000%

$0.00

−100.0%

Hunter C Smith

Chief Financial Officer

—

$8.84M (26) scheduled

−$8.84M

114,024

0.1656%

$11.99M

+16.4%

Yann Mazabraud

EVP, Head of International

—

$6.62M (6) scheduled

−$6.62M

55,655

0.0808%

$5.85M

+59.6%

David P Meeker

President and CEO

—

$5.13M (5) scheduled

−$5.13M

239,258

0.3475%

$25.17M

+32.3%

Lynn A. Tetrault

Director

—

$3.71M (1) scheduled

−$3.71M

11,712

0.0170%

$1.23M

+290.4%

Pamela J. Cramer

Chief Human Resources Officer

—

$2.99M (4) scheduled

−$2.99M

29,376

0.0427%

$3.09M

+117.6%

Christopher Paul German

Corporate Controller & CAO

—

$930.92K (2) scheduled

−$930.92K

0.0000%

$0.00

−100.0%

Alastair Garfield

Chief Scientific Officer

—

$912.70K (4) scheduled

−$912.70K

2,295

0.0033%

$241.41K

—

Joseph Shulman

Chief Technical Officer

—

$608.21K (1) scheduled

−$608.21K

15,915

0.0231%

$1.67M

—

Edward T Mathers

Director

—

21,168

0.0307%

$2.23M

+141.3%

Stuart A Arbuckle

Director

—

11,712

0.0170%

$1.23M

+290.4%

David W J McGirr

Director

—

11,712

0.0170%

$1.23M

+290.4%

Christophe Jean

Director

—

11,712

0.0170%

$1.23M

+290.4%

Jennifer L Good

Director

—

11,712

0.0170%

$1.23M

+290.4%

Camille L Bedrosian

Director

—

7,000

0.0102%

$736.33K

+133.3%

RHYTHM PHARMACEUTICALS, INC.

What the insiders did Scheduled selling only

By person